InsidersTradesSigma
AddLife AB Stock: price and insider trades · Finland · FIN-FSA
Track the AddLife AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, AddLife AB has published 22 insider filings. Market capitalisation: €20.7bn. The latest transaction was filed on 11 June 2026 (Sale). Among the most active insiders: Fredrik Dalborg. All data is openly available.
22
Insider Decl.
0
Thresholds
€364,345
15 ops.
Buy Volume
€351,410
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AddLife AB Strong Buy (bullish), based on 3 analysts. Average price target: SEK 196.67.
35Σ signal
Fundamental score
Ranked 12,311 of 25,927 companies
53.3
score / 100
Value53
Quality53
FCF yld5.8%
Earn yld2.9%
EV/EBITDA13.4x
ROE11%
Gross mgn38%
Net mgn5.4%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 June 2026
Declarations22 total
2,500 shares@ SEK 155.980.0002% mcap21.6% of flowAktieFI:csv-c64b69e8c4aa206c3f6f
2,663 shares@ SEK 156.830.0002% mcap23.1% of flowAktieFI:csv-e9399199fe03f8313835
6,000 shares@ SEK 157.100.0004% mcap52.2% of flowAktieFI:csv-568d3c16583f3dd74b88
Ideal exit: 6 Mar 2027 (T+270)
1,000 shares@ SEK 141.920.0001% mcap5.8% of flowAktieFI:csv-fb82bbca5e9c24465a06
Ideal exit: 28 Feb 2027 (T+270)
1,000 shares@ SEK 141.920.0001% mcap6.2% of flowAktieFI:A003Z544-1
Ideal exit: 28 Feb 2027 (T+270)
5,500 shares@ €13.02110.0004% mcap36.5% of flowAktieFI:A003Y307-1
Ideal exit: 2 Feb 2027 (T+270)
200 shares@ €12.9750.0000% mcap9.9% of flowAktieFI:A003W180-1
Ideal exit: 15 Nov 2026 (T+270)
2,000 shares@ €13.09490.0002% mcap100.0% of flowAktieFI:A003V888-1
Ideal exit: 8 Nov 2026 (T+270)
1,000 shares@ €14.03870.0001% mcap7.2% of flowAktieFI:A003V702-1
Ideal exit: 3 Nov 2026 (T+270)
549 shares@ €16.58860.0001% mcap34.8% of flowAktieFI:A003U478-1
Ideal exit: 1 Sept 2026 (T+270)
800 shares@ €16.55210.0001% mcap6.8% of flowAktieFI:A003U450-1
Ideal exit: 1 Sept 2026 (T+270)
300 shares@ €17.13160.0000% mcap100.0% of flowAktieFI:A003T578-1
115 shares@ €15.560.0000% mcap6.8% of flowAktieFI:A003R186-1
Ideal exit: 25 Apr 2026 (T+270)
1,200 shares@ €15.33250.0001% mcap9.4% of flowAktieFI:A003Q694-1
Ideal exit: 12 Apr 2026 (T+270)
7,713 shares@ €17.69570.0008% mcap100.0% of flowAktieFI:A003P546-1
25 shares@ €17.45610.0000% mcap100.0% of flowAktieFI:A003P357-1
Ideal exit: 2 Mar 2026 (T+270)
4,500 shares@ €17.49980.0005% mcap40.2% of flowAktieFI:A003P351-1
Ideal exit: 2 Mar 2026 (T+270)
200 shares@ €17.06210.0000% mcap100.0% of flowAktieFI:A003P348-1
Ideal exit: 1 Mar 2026 (T+270)
750 shares@ €16.95470.0001% mcap48.5% of flowAktieFI:A003P104-1
Ideal exit: 21 Feb 2026 (T+270)
665 shares@ SEK 92.80100.0% of flowKöpoptionFI:A001Q896-1
5,000 shares@ SEK 92.80100.0% of flowKöpoptionFI:A001Q889-1
24,000 shares@ SEK 92.80100.0% of flowKöpoptionFI:A001Q885-1
22 of 22 declarations
About AddLife AB
AddLife AB is a Swedish company operating in the health and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).